Camber Capital Management

Latest statistics and disclosures from Camber Capital Management's latest quarterly 13F-HR filing:

Companies in the Camber Capital Management portfolio as of June 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Gilead Sciences (GILD) 13.82 4.00M +37% 70.78
SPDR S&P; 500 ETF (SPY) 11.80 1000000 -66% 241.80
Teva Pharmaceutical Industries (TEVA) 10.16 6.27M +20% 33.22
Mylan Nv 8.04 4.25M +2% 38.82
Nektar Therapeutics (NKTR) 5.10 5.35M 19.55
Allergan 4.15 350000 -19% 243.09
Genomic Health (GHDX) 3.91 2.46M 32.55
Brookdale Senior Living (BKD) 3.88 5.40M 14.71
Myriad Genetics (MYGN) 3.78 3.00M -30% 25.84
Tenet Healthcare Corporation stock 3.78 4.00M NEW 19.34
Select Medical Holdings Corporation (SEM) 3.75 5.00M 15.35
Bioverativ Inc Com equity 3.45 1.17M +6% 60.17
Orthofix International Nv Com Stk 3.40 1.50M 46.48
Vertex Pharmaceuticals Incorporated (VRTX) 2.20 350000 -46% 128.87
Sarepta Therapeutics 2.14 1.30M -3% 33.71
Endo International 1.95 3.57M -29% 11.17
Endologix (ELGX) 1.78 7.50M +25% 4.86
AMAG Pharmaceuticals (AMAG) 1.53 1.70M NEW 18.40
BioScrip (BIOS) 1.35 10.18M 2.72
Biogen Idec (BIIB) 1.32 100000 NEW 271.36
Syneron Medical Ltd ord shs 1.25 2.35M 10.95
Alexion Pharmaceuticals (ALXN) 1.19 200000 NEW 121.67
Axovant Sciences 1.13 1000000 NEW 23.19
Invitae 1.12 2.40M 9.56
Envision Healthcare 1.07 350000 NEW 62.67
Avexis 0.84 210000 NEW 82.16
Rite Aid Corporation (RAD) 0.72 5.00M NEW 2.95
Ptc Therapeutics I 0.45 500000 -60% 18.33
Atara Biotherapeutics 0.37 535500 +328% 14.00
Arena Pharmaceuticals (ARNA) 0.35 425000 -90% 16.87
Radius Health 0.22 100000 NEW 45.23
Biolase Technology (BLTI) 0.00 7.17M 0.00

Past 13F-HR SEC Filings by Camber Capital Management

View All Filings